tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ELDN Stock Latest News

Buy Rating for Eledon Pharmaceuticals: Promising Kidney Transplant Treatment and Strong Financial Position
RatingsBuy Rating for Eledon Pharmaceuticals: Promising Kidney Transplant Treatment and Strong Financial Position
1d ago
ELDN
Eledon Pharmaceuticals reports Q2 EPS (13c), consensus (23c)
PremiumThe Fly
Eledon Pharmaceuticals reports Q2 EPS (13c), consensus (23c)
2d ago
ELDN
Positive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
PremiumRatings
Positive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
8d ago
ELDN
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals
PremiumRatings
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals
9d ago
ELDN
Eledon Pharmaceuticals announces updated data from tegoprubart trial
PremiumThe Fly
Eledon Pharmaceuticals announces updated data from tegoprubart trial
9d ago
ELDN
Eledon Pharmaceuticals Reports Promising Phase 1b Trial Results
PremiumCompany AnnouncementsEledon Pharmaceuticals Reports Promising Phase 1b Trial Results
10d ago
8K
ELDN
Craig-Hallum bullish on Eledon Pharmaceuticals, initiates with a Buy
Premium
The Fly
Craig-Hallum bullish on Eledon Pharmaceuticals, initiates with a Buy
22d ago
ELDN
Eledon Pharmaceuticals initiated with a Buy at Craig-Hallum
Premium
The Fly
Eledon Pharmaceuticals initiated with a Buy at Craig-Hallum
22d ago
ELDN
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart
PremiumCompany Announcements
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart
23d ago
ELDN
Eledon Pharmaceuticals: Promising Advances in Organ Transplant Rejection Prevention with Tegoprubart
PremiumRatings
Eledon Pharmaceuticals: Promising Advances in Organ Transplant Rejection Prevention with Tegoprubart
1M ago
ELDN
Eledon Pharmaceuticals’ Tegoprubart: Promising Clinical Potential in Kidney Transplantation and Strategic Targeting Advantages
PremiumRatings
Eledon Pharmaceuticals’ Tegoprubart: Promising Clinical Potential in Kidney Transplantation and Strategic Targeting Advantages
1M ago
ELDN
Sernova enters collaborative research agreement with Eledon Pharmaceuticals
PremiumThe Fly
Sernova enters collaborative research agreement with Eledon Pharmaceuticals
1M ago
ELDN
Eledon Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe FlyEledon Pharmaceuticals assumed with a Buy at H.C. Wainwright
2M ago
ELDN
Eledon Pharmaceuticals: Promising Kidney Transplant Treatment Spurs Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Promising Kidney Transplant Treatment Spurs Buy Rating
2M ago
ELDN
Eledon Pharmaceuticals Holds Annual Stockholders Meeting
Premium
Company Announcements
Eledon Pharmaceuticals Holds Annual Stockholders Meeting
2M ago
8K
ELDN
Eledon Pharmaceuticals Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
Eledon Pharmaceuticals Reports Q1 2025 Progress and Financials
3M ago
ELDN
Eledon Pharmaceuticals: Strong Financials and Promising Trials Justify Buy Rating
PremiumRatings
Eledon Pharmaceuticals: Strong Financials and Promising Trials Justify Buy Rating
3M ago
ELDN
Eledon Pharmaceuticals reports Q1 EPS (8c), consensus (30c)
PremiumThe Fly
Eledon Pharmaceuticals reports Q1 EPS (8c), consensus (30c)
3M ago
ELDN
Eledon Pharmaceuticals Reports 2024 Financial Results and Clinical Advances
PremiumCompany Announcements
Eledon Pharmaceuticals Reports 2024 Financial Results and Clinical Advances
5M ago
ELDN
Eledon Pharmaceuticals: Promising Developments in Organ Transplantation and Diabetes Therapies Drive Buy Rating
PremiumRatingsEledon Pharmaceuticals: Promising Developments in Organ Transplantation and Diabetes Therapies Drive Buy Rating
5M ago
ELDN
Eledon Pharmaceuticals: Promising Developments and Financial Stability Justify Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Promising Developments and Financial Stability Justify Buy Rating
5M ago
ELDN
Eledon announces tegoprubart use in transplant of pig kidney into human
Premium
The Fly
Eledon announces tegoprubart use in transplant of pig kidney into human
6M ago
ELDN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >